Living Donor Liver Transplantation with Small Left Lobe Grafts: Prospective Validation of Utility of Splenectomy in Selected Recipients

Hajime Matsushima; Akihiko Soyama; Takanobu Hara; Takashi Hamada; Yuta Kawaguchi; Kazushige Migita; Ayaka Satoh; Yamashita Mampei; Hajime Imamura; Ayaka Kinoshita; Tomohiko Adachi; Susumu Eguchi

doi:10.12659/AOT.946374

14 January 2025 : Original article

Living Donor Liver Transplantation with Small Left Lobe Grafts: Prospective Validation of Utility of Splenectomy in Selected Recipients

Hajime Matsushima^1ABCDEF*, Akihiko Soyama

^1BCD, Takanobu Hara

^1BCD, Takashi Hamada

^1BCD, Yuta Kawaguchi^1BCD, Kazushige Migita^1BCD, Ayaka Satoh^1BCD, Yamashita Mampei

^1BCD, Hajime Imamura

^1BCD, Ayaka Kinoshita^1BCD, Tomohiko Adachi^1BCD, Susumu Eguchi^1BCD

DOI: 10.12659/AOT.946374

Ann Transplant 2025; 30:e946374

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 Our current algorithm for treating patients receiving left lobe grafts with splenectomy in era 3. Before March 2021 (era 1 and era 2), splenectomy during living donor liver transplantation (LDLT) was indicated only when the platelet count at the time of transplantation was <50 000/μL due to hypersplenism.

Back to the Article

Living Donor Liver Transplantation with Small Left Lobe Grafts: Prospective Validation of Utility of Splenectomy in Selected Recipients

Your Privacy